Mirae Asset Global Investments’s Applied Therapeutics APLT Stock Holding History

Mirae Asset Global Investments’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,568	Closed	-$3.37K	–	1649
2025 Q3	$3.37K	Buy	5,568 +99	+2%	+$47	﹤0.01%	1623
2025 Q2	$1.7K	Buy	5,469 +1,650	+43%	+$638	﹤0.01%	1567
2025 Q1	$1.97K	Sell	3,819 -58	-1%	-$34	﹤0.01%	1538
2024 Q4	$3.31K	Buy	+3,877	New	+$24.3K	﹤0.01%	1573
2022 Q3	–	Sell	-30,669	Closed	-$298K	–	2590
2022 Q2	$298K	Buy	+30,669	New	+$50.2K	﹤0.01%	1991

Other funds holding APLT

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Mirae Asset Global Investments's APLT Position: Q4 2025 in Review

Mirae Asset Global Investments sold out of Applied Therapeutics (APLT) in Q4 2025, closing a stake of 5,568 shares — an estimated $3.37K sold.

Mirae Asset Global Investments first reported a position in APLT in Q2 2022 and held it in 5 quarters. The position peaked at $298K in Q2 2022. 52 funds tracked by Wall St. Rank hold APLT as of Q4 2025.

Mirae Asset Global Investments reported no remaining Applied Therapeutics position as of Q4 2025 after selling out during the quarter.
Mirae Asset Global Investments sold 5,568 Applied Therapeutics shares in Q4 2025, an estimated $3.37K.
Mirae Asset Global Investments first reported a position in Applied Therapeutics in Q2 2022 and held it in 5 quarters.
Mirae Asset Global Investments's Applied Therapeutics position peaked at $298K in Q2 2022.
52 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2025.

Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.